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Does fish oil during pregnancy 
help prevent asthma in kids?
The evidence on fish oil has been mixed, but this study 
affirms its benefits—in certain women.
PRACTICE CHANGER
Fish oil supplementation taken by women in 
the third trimester of pregnancy can reduce 
the risk of persistent wheeze, asthma, and in-
fections of the lower respiratory tract in their 
children.1 
STRENGTH OF RECOMMENDATION
B: Based on 2 double-blinded randomized 
controlled trials (RCTs).
Bisgaard H, Stokholm J, Chawes BL, et al. Fish oil-derived fatty ac-
ids in pregnancy and wheeze and asthma in offspring. N Engl J Med. 
2016;375:2530-2539.1
ILLUSTRATIVE CASE
A 24-year-old G2P1 at 24 weeks’ gestation 
presents to your clinic for a routine prenatal 
visit. Her older daughter has asthma and she is 
inquiring as to whether there is anything she 
can do to lower the risk of her second child 
developing asthma in the future. What do you 
recommend?
Asthma is the most common chronic disease in children in resource-rich countries such as the United States.2 
The Centers for Disease Control and Preven-
tion (CDC) reported that 8.4% of children 
were diagnosed with asthma in 2015.3 
Omega-3 fatty acids, found naturally 
in fish oil, are thought to confer anti- 
inflammatory properties that offer protection 
against asthma. Clinical trials have shown 
that fish oil supplementation in pregnancy 
results in higher levels of omega-3 fatty acids, 
along with anti-inflammatory changes, in off-
spring.4 Previous epidemiologic studies have 
also found that consumption of omega-3 fatty 
acids decreased the risk of atopy and asthma 
in offspring.5,6 
❚ A Cochrane review published in 2015, 
however, concluded that omega-3 supple-
mentation during pregnancy had no ben-
efit on wheeze or asthma in offspring.7 Five 
RCTs were included in the analysis. The 
largest trial by Palmer et al, which included 
706 women, showed no benefit for omega-3 
supplementation.8 The second largest by Ol-
sen et al, which included 533 women, did 
show a benefit (hazard ratio [HR]=0.37; 95% 
confidence interval [CI], 0.15-0.92; number 
needed to treat [NNT]=19.6).9 
These results, however, were limited 
by heterogeneity in the amount of fish oil 
supplemented and duration of follow-up. 
For example, the children in the Palmer 
study were followed only until 3 years of age, 
which is around the time that asthma can be 
formally diagnosed, potentially leading to 
under-reporting.8 In addition, the diagno-
sis of asthma was based on parent report of 
3 episodes of wheezing, use of daily asthma 
medication, or use of a national registry—all 
of which can underestimate the incidence 
of asthma. The reported rate of childhood 
asthma with IgE-sensitization (they did not 
report the rate without sensitization) was 
1.8% in both arms, which is much lower than 
the CDC’s rate of 8.4%, suggesting under-
diagnosis.3,8 Due to these biases and other 
potential confounders, no firm conclusions 
can be drawn from the Cochrane review. 
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STUDY SUMMARY
Maternal fish oil supplementation  
reduces incidence of asthma in children
This single-center, double-blinded RCT of 
736 pregnant women evaluated the effect of 
2.4 g/d of n-3 long-chain polyunsaturated 
fatty acids (eicosapentaenoic acid [EPA] and 
docosahexaenoic acid [DHA]) or placebo (ol-
ive oil), starting at an estimated gestational 
age of 24 to 26 weeks, on wheeze or asthma 
incidence in their offspring.1 
Eligible women were between 22 and 
26 weeks’ pregnant at the time of recruitment. 
Exclusion criteria included supplementa-
tion of 600 IU/d or more of vitamin D, or hav-
ing any endocrine, cardiac, or renal disorders. 
The investigators randomized the women in a 
1:1 ratio to either fish oil or placebo. Maternal 
EPA and DHA blood levels were tested at the 
time of randomization and one week after birth.
❚ The primary outcome was persistent 
wheeze or asthma (after 3 years of age, the 
diagnosis of persistent wheeze was termed 
asthma) based on daily diary recordings of 
5 episodes of troublesome lung symptoms 
within the last 6 months (each lasting for at 
least 3 consecutive days), rescue use of in-
haled beta2-agonists, and/or relapse after a 
3-month course of inhaled glucocorticoids. 
Secondary outcomes included lower respira-
tory tract infections, asthma exacerbations, 
eczema, and allergic sensitization. 
In total, 695 offspring were included in 
the study with 95.5% follow-up at 3 years and 
93.1% follow-up at 5 years. The children had 
scheduled pediatric visits at 1 week; 1, 3, 6, 
12, 18, 24, 30, and 36 months; and at 4 and 
5 years, and acute visits for any pulmonary, al-
lergic, or dermatologic symptoms that arose. 
❚ Results. The investigators found that 
the children of the mothers who received 
the fish oil had a lower risk of persistent 
wheeze or asthma at ages 3 to 5 years com-
pared to those who received placebo (16.9% 
vs 23.7%; HR=0.69; 95% CI, 0.49-0.97; P=.035; 
NNT=14.7). But the effect of the fish oil 
supplementation was significant only in the 
children of the mothers with baseline EPA 
and DHA levels in the lowest third (17.5% vs 
34.1%; HR=0.46; 95% CI, 0.25-0.83; P=.011; 
NNT=5.6). Similarly, in mothers who con-
sumed the least EPA and DHA before the start 
of the study, fish oil supplementation had a 
greater benefit in terms of decreased wheeze 
and asthma (18.5% vs 32.4%; HR=0.55; 95% 
CI, 0.30-0.98; P=.043; NNT=7.2). 
As for the secondary outcomes, only a re-
duction in lower respiratory tract infections was 
associated with the fish oil supplementation vs 
the control (38.8% vs 45.5%; HR=0.77; 95% CI, 
0.61-0.99; P=.041; NNT=14.9). There was no 
reduction in asthma exacerbations, eczema, or 
risk of sensitization in the fish oil group.
WHAT’S NEW?
Study adds fuel to the fire
This study strengthens the case for fish oil sup-
plementation during pregnancy to reduce the 
risk of asthma in offspring, despite the recent 
Cochrane review that showed no benefit.1,7 The 
Palmer study used a much lower amount of 
omega-3s (900 mg/d fish oil vs 2400 mg/d in 
the current trial).1,8 Olsen et al supplemented 
with a greater amount of omega-3s (2700 mg/d) 
and did find a benefit.9 The NNT from the Olsen 
study (19.6) is consistent with that of the current 
investigation, suggesting that a higher dosage 
may be necessary to prevent the onset of asthma. 
Additionally, this study followed children 
for a longer period than did the Palmer study, 
which may have led to more accurate diagno-
ses of asthma.1,8 Lastly, the diagnosis of asthma 
in the Palmer study was based on parent survey 
data and use of daily asthma medicine rather 
than on daily diary cards, which are often more 
accurate. 
❚ Consider fish consumption. Both this 
study and the Olsen trial were performed in 
Denmark.1,9 While Denmark and the United 
States have had a relatively similar level of 
fish consumption since the 1990s, women in 
Denmark may eat a higher proportion of oily 
fish than women in the United States, given 
the more common inclusion of mackerel 
and herring in their diet.10 Thus, the effect of 
supplementation may be more pronounced 
in women in the United States.
CAVEATS
Questions remain: Ideal dose  
and which women to treat?
The US Food and Drug Administration cur-
This study 
strengthens the 
case for fish oil 
supplementation 
during  
pregnancy to 
reduce the risk 
of asthma  
in children.
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Only women 
whose blood 
levels of EPA 
and DHA are 
low to begin 
with will likely 
benefit from this 
intervention.
rently recommends 8 to 12 ounces of fish 
per week for pregnant women, but there are 
no guidelines on the ideal amount of fish oil 
to be consumed.11 The Palmer study,8 using 
900 mg/d fish oil, did not show a benefit, 
whereas there did appear to be benefit in 
this study (2400 mg/d)1 and the Olsen study 
(2700 mg/d).9 Further research is needed to 
determine the optimal dosage. 
The decreased risk of persistent wheeze 
or asthma was seen only in the children of 
the women whose EPA and DHA blood levels 
were in the lowest third of the study popula-
tion. Thus, only women whose blood levels 
are low to begin with will likely benefit from 
this intervention. Currently, EPA and DHA 
levels are not routinely checked, but there 
may be some benefit to doing so. 
One proxy for blood levels is maternal 
intake of fish at baseline. The investigators 
found that there was an association between 
dietary intake of fish and blood levels of EPA 
and DHA (r=0.32; P<.001).1 Therefore, ad-
ditional screening questions to determine 
fish consumption would be useful for iden-
tifying women most likely to benefit from 
supplementation. 
CHALLENGES TO IMPLEMENTATION
Multiple pills and additional cost
Since omega-3 fatty acids are relatively safe 
and the NNT in the general population is 
low, it may be worth supplementing all preg-
nant women, even without a commercially- 
available blood test for EPA or DHA. Never-
theless, some women may find it challeng-
ing to take up to an additional 4 pills/d for 
13 or more weeks. Also, there is an associ-
ated cost with these supplements, although it 
is low.                                JFP
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